Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma. 2020

Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria. dominik.berzaczy@meduniwien.ac.at.

To assess the diagnostic performance of simultaneous whole-body 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) compared to [18F]FDG PET/x-ray computed tomography (CT) for detection of distant metastatic disease in patients with malignant melanoma. We included patients with malignant melanoma who underwent a single injection [18F]FDG dual-imaging protocol that included whole-body PET/CT and subsequent whole-body PET/MRI for staging or restaging purposes in a prospective setting. Images from both modalities were analyzed by two rater teams for the presence of metastatic lesions. PET/CT-PET/MRI overall agreement as well as region-based accuracies, sensitivities (Se), and specificities (Sp) were computed. Between July 2014 and December 2018, 22 patients were enrolled. Interrater agreement and overall accuracy (consensus reading) were 78.8 % (95 % CI 71-84.9) and 96.1 % (95 % CI 92.3-98) for PET/MRI and 78 % (70.2-84.3) and 97.4 % (95 % CI 93.7-98.9) for PET/CT, respectively (P = 0.42). PET/MRI reached a region-based Se of 89.1 % (95 % CI 79.4-94.5) and a Sp of 100 %, whereas PET/CT showed a region-based Se of 92.7 % (95 % CI 84-96.9) and a Sp of 100 % for the detection of metastatic disease in malignant melanoma. Whole-body [18F]FDG-PET/MRI appears to be comparable to [18F]FDG-PET/CT for lesion detection in patients with malignant melanoma.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072078 Positron Emission Tomography Computed Tomography An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session. CT PET,CT PET Scan,PET CT Scan,PET-CT,PET-CT Scan,Positron Emission Tomography-Computed Tomography,CT PET Scans,CT Scan, PET,CT Scans, PET,PET CT Scans,PET Scan, CT,PET Scans, CT,PET-CT Scans,Scan, CT PET,Scan, PET CT,Scan, PET-CT,Scans, CT PET,Scans, PET CT,Scans, PET-CT
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission

Related Publications

Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
November 2013, Clinical nuclear medicine,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
December 2023, European journal of hybrid imaging,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
October 2018, Molecular imaging and radionuclide therapy,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
October 2023, Abdominal radiology (New York),
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
March 2012, La Radiologia medica,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
June 2013, Abdominal imaging,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
January 2010, Nuklearmedizin. Nuclear medicine,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
January 2017, PloS one,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
February 2015, Der Radiologe,
Dominik Berzaczy, and Barbara Fueger, and Christoph Hoeller, and Alexander R Haug, and Anton Staudenherz, and Gundula Berzaczy, and Michael Weber, and Marius E Mayerhoefer
September 2004, Der Radiologe,
Copied contents to your clipboard!